The researchers looked at clinical outcomes for 163 bypass surgery patients 30 days after PCI. The first group consisted of 60 patients who underwent PCI using a distal protection device alone, and the second group included 103 patients who underwent PCI with a distal protection device and pre-treatment with prophylactic nicardipine.
The researchers found mortality, heart attack, bypass or repeat PCI occurred in 10 percent of patients in the first group 30 days after the original PCI. In contrast, patients in the second group only saw 1 percent rates for mortality, heart attack, bypass or repeat PCI.
More Articles on Patient Safety:
Turning Heart Failure Into Heart Success: Transitioning CHF Patients to Home
Study: Lean Approach Speeds Treatment for Stroke Patients
oofing Fumes Cause Loma Linda ER Evacuation
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
